Ninnie Borendal Wodlin
Papers
3
Total Citations
88
H-Index
3
About
Ninnie Borendal Wodlin is a leading researcher in gynecologic oncology, with a focused expertise in comparing surgical approaches for early endometrial cancer. Her work centers on evaluating the clinical and economic trade-offs between robotic-assisted and traditional abdominal hysterectomy. Borendal Wodlin’s major contributions include landmark randomized controlled trials that assess not only surgical outcomes but also patient-centered metrics like quality of life and perioperative physiological responses. Her 2020 cost-effectiveness analysis (37 citations) provides crucial evidence for healthcare decision-making, demonstrating the economic viability of robotic surgery. Complementing this, her 2019 prospective study (28 citations) rigorously compared patient-reported quality of life between the two methods. Perhaps most notably, her 2020 trial (23 citations) uniquely investigated biomarkers of tissue damage and inflammation, offering mechanistic insights into why robotic surgery may reduce surgical trauma. Conducted at a Swedish university hospital, this work has shaped clinical protocols by providing a comprehensive, multi-dimensional evaluation of surgical innovation. Borendal Wodlin’s research is instrumental for clinicians and policymakers seeking to balance improved patient recovery with healthcare resource allocation.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3